Pharmaceutical companies have always been the biggest cleanroom users — they make sterile injectables, eye drops, and inhalers. But biotechnology is the fastest‑growing end‑user segment. The cleanroom technology market research study shows that biotech is growing at over 9% CAGR, driven by cell and gene therapies. These are not your grandma's pills — they're living cells that must be handled in pristine conditions.

What's the difference? Pharma cleanrooms are often large, permanent, and built for high‑volume production. Biotech cleanrooms are smaller, modular, and designed for flexibility — because a startup might change its process every few months. The cleanroom technology market trends highlight that the fastest‑growing type is modular cleanrooms, which are perfect for biotech.

What's new? Cleanrooms for mRNA vaccines. The pandemic created a boom in mRNA production, which requires ultra‑clean environments. Many companies are now building dedicated mRNA cleanrooms.

The takeaway: if you're in biotech, invest in modular cleanrooms. They give you flexibility. If you're in pharma, focus on automation and efficiency. Both sectors are growing, but for different reasons.